100 related articles for article (PubMed ID: 16799155)
1. The transcriptional ETS2 repressor factor associates with active and inactive Erks through distinct FXF motifs.
Polychronopoulos S; Verykokakis M; Yazicioglu MN; Sakarellos-Daitsiotis M; Cobb MH; Mavrothalassitis G
J Biol Chem; 2006 Sep; 281(35):25601-11. PubMed ID: 16799155
[TBL] [Abstract][Full Text] [Related]
2. Role of non-phosphorylated activation loop residues in determining ERK2 dephosphorylation, activity, and subcellular localization.
Bendetz-Nezer S; Seger R
J Biol Chem; 2007 Aug; 282(34):25114-22. PubMed ID: 17597065
[TBL] [Abstract][Full Text] [Related]
3. Suppression of Fgf2 by ETS2 repressor factor (ERF) is required for chorionic trophoblast differentiation.
Vorgia E; Zaragkoulias A; Peraki I; Mavrothalassitis G
Mol Reprod Dev; 2017 Apr; 84(4):286-295. PubMed ID: 28244611
[TBL] [Abstract][Full Text] [Related]
4. Proteins of the ETS family with transcriptional repressor activity.
Mavrothalassitis G; Ghysdael J
Oncogene; 2000 Dec; 19(55):6524-32. PubMed ID: 11175368
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and biological functions of the N-terminal, noncatalytic domain of extracellular signal-regulated kinase 2.
Eblen ST; Catling AD; Assanah MC; Weber MJ
Mol Cell Biol; 2001 Jan; 21(1):249-59. PubMed ID: 11113199
[TBL] [Abstract][Full Text] [Related]
6. Calcium-Mediated Interactions Regulate the Subcellular Localization of Extracellular Signal-Regulated Kinases (ERKs).
Chuderland D; Marmor G; Shainskaya A; Seger R
Cell Physiol Biochem; 2020 May; 54(3):474-492. PubMed ID: 32392404
[TBL] [Abstract][Full Text] [Related]
7. ERF: genomic organization, chromosomal localization and promoter analysis of the human and mouse genes.
Liu D; Pavlopoulos E; Modi W; Moschonas N; Mavrothalassitis G
Oncogene; 1997 Mar; 14(12):1445-51. PubMed ID: 9136988
[TBL] [Abstract][Full Text] [Related]
8. The RAS-dependent ERF control of cell proliferation and differentiation is mediated by c-Myc repression.
Verykokakis M; Papadaki C; Vorgia E; Le Gallic L; Mavrothalassitis G
J Biol Chem; 2007 Oct; 282(41):30285-94. PubMed ID: 17699159
[TBL] [Abstract][Full Text] [Related]
9. Differential repression of c-myc and cdc2 gene expression by ERF and PE-1/METS.
Hester KD; Verhelle D; Escoubet-Lozach L; Luna R; Rose DW; Glass CK
Cell Cycle; 2007 Jul; 6(13):1594-604. PubMed ID: 17525531
[TBL] [Abstract][Full Text] [Related]
10. Identification of nuclear localization and nuclear export signals in Ets2, and the transcriptional regulation of Ets2 and CTP:phosphocholine cytidylyltransferase alpha in tetradecanoyl-13-acetate or macrophage-colony stimulating factor stimulated RAW264 cells.
Okamura K; Yamashita S; Ando H; Horibata Y; Aoyama C; Takagishi K; Izumi T; Vance DE; Sugimoto H
Biochim Biophys Acta; 2009 Mar; 1791(3):173-82. PubMed ID: 19168148
[TBL] [Abstract][Full Text] [Related]
11. Selective inhibition of prolactin gene transcription by the ETS-2 repressor factor.
Day RN; Liu J; Sundmark V; Kawecki M; Berry D; Elsholtz HP
J Biol Chem; 1998 Nov; 273(48):31909-15. PubMed ID: 9822660
[TBL] [Abstract][Full Text] [Related]
12. Calcium-mediated interactions regulate the subcellular localization of extracellular signal-regulated kinases.
Chuderland D; Marmor G; Shainskaya A; Seger R
J Biol Chem; 2008 Apr; 283(17):11176-88. PubMed ID: 18268018
[TBL] [Abstract][Full Text] [Related]
13. EGF suppresses the expression of miR-124a in pancreatic β cell lines via ETS2 activation through the MEK and PI3K signaling pathways.
Yang L; Zhu Y; Kong D; Gong J; Yu W; Liang Y; Nie Y; Teng CB
Int J Biol Sci; 2019; 15(12):2561-2575. PubMed ID: 31754329
[TBL] [Abstract][Full Text] [Related]
14. ERF, an ETS-related transcriptional repressor, can induce erythroid differentiation.
Athanasiou M; Blair DG; Mavrothalassitis G
Anticancer Res; 2003; 23(3A):2143-53. PubMed ID: 12894589
[TBL] [Abstract][Full Text] [Related]
15. Selective targeting of MAPKs to the ETS domain transcription factor SAP-1.
Galanis A; Yang SH; Sharrocks AD
J Biol Chem; 2001 Jan; 276(2):965-73. PubMed ID: 11029469
[TBL] [Abstract][Full Text] [Related]
16. ERF mutations reveal a balance of ETS factors controlling prostate oncogenesis.
Bose R; Karthaus WR; Armenia J; Abida W; Iaquinta PJ; Zhang Z; Wongvipat J; Wasmuth EV; Shah N; Sullivan PS; Doran MG; Wang P; Patruno A; Zhao Y; ; Zheng D; Schultz N; Sawyers CL
Nature; 2017 Jun; 546(7660):671-675. PubMed ID: 28614298
[TBL] [Abstract][Full Text] [Related]
17. Elevated expression of Ets2 or distinct portions of Ets2 can reverse Ras-mediated cellular transformation.
Foos G; García-Ramírez JJ; Galang CK; Hauser CA
J Biol Chem; 1998 Jul; 273(30):18871-80. PubMed ID: 9668063
[TBL] [Abstract][Full Text] [Related]
18. Intrinsically active variants of Erk oncogenically transform cells and disclose unexpected autophosphorylation capability that is independent of TEY phosphorylation.
Smorodinsky-Atias K; Goshen-Lago T; Goldberg-Carp A; Melamed D; Shir A; Mooshayef N; Beenstock J; Karamansha Y; Darlyuk-Saadon I; Livnah O; Ahn NG; Admon A; Engelberg D
Mol Biol Cell; 2016 Mar; 27(6):1026-39. PubMed ID: 26658610
[TBL] [Abstract][Full Text] [Related]
19. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction.
Venanzoni MC; Robinson LR; Hodge DR; Kola I; Seth A
Oncogene; 1996 Mar; 12(6):1199-1204. PubMed ID: 8649821
[TBL] [Abstract][Full Text] [Related]
20. Altered regulation of ERK1b by MEK1 and PTP-SL and modified Elk1 phosphorylation by ERK1b are caused by abrogation of the regulatory C-terminal sequence of ERKs.
Yung Y; Yao Z; Aebersold DM; Hanoch T; Seger R
J Biol Chem; 2001 Sep; 276(38):35280-9. PubMed ID: 11463794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
